Delivery Order 36C26326D0009-36C26326N0208
- Not listed
- This is a federal contract award to Vitalant, a non-profit organization that serves as a leading independent blood services provider in the United States. The contract, valued at $237,812.46, is for the delivery of blood and blood products to the U.S. Department of Veterans Affairs' Veterans Integrated Service Network 22. The contract has a period of performance ending on April 15, 2025 and is a firm fixed-price delivery order with no set-aside designation. Vitalant has been awarded numerous...
- This is a federal contract award to Vitalant, a non-profit organization that serves as a leading independent blood services provider in the United States. The contract, valued at $447,231.65, is for the delivery of blood and blood products to the U.S. Department of Veterans Affairs' Veterans Integrated Service Network 22. The contract has an ultimate completion date of April 11, 2025, and is a firm fixed-price delivery order. Vitalant is the prime contractor, and the contract does not have a...
- This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs Veterans Health Administration to Vitalant, a nonprofit organization that specializes in blood collection and testing services. The $238,845.98 contract is for providing blood and blood products to the VA's Veterans Integrated Service Network 21, with performance in Scottsdale, Arizona. Vitalant, through its Vitalant Research Institute division, has held numerous federal contracts and grants to supply blood...
- This federal contract award was issued by the Veterans Integrated Service Network 20, a civilian agency, to Vitalant, a non-profit organization, for the delivery of blood products. The contract is a firm fixed-price delivery order with a ceiling value of $78,929.52 and an ultimate completion date of July 31, 2026. The contract is not set aside for any specific business type, indicating Vitalant's ability to compete effectively in open federal procurement processes. Vitalant is a leading...
- This is a firm fixed-price delivery order contract awarded by the Veterans Integrated Service Network 22 (VISN 22) of the Department of Veterans Affairs (VA) to Vitalant, a non-profit organization specializing in blood services. The contract, valued at $115,944.69, is for the provision of blood products and services to support VA healthcare facilities in Phoenix, Prescott, and Albuquerque. The contract has an ultimate completion date of September 30, 2029. Vitalant, through its research division...
- This is a federal contract award from the Veterans Integrated Service Network 19, a civilian agency, to Vitalant, a non-profit organization headquartered in Scottsdale, Arizona. The contract is for the provision of human blood and blood products, with a ceiling value of $979,380.63 and a period of performance ending on September 30, 2026. The contract is a Blanket Purchase Agreement (BPA) call, with a firm fixed price pricing type. Vitalant, through its research division Vitalant Research...
- This is a firm fixed-price delivery order contract awarded by the Veterans Integrated Service Network 22 (VISN 22), a civilian agency, to Vitalant, a non-profit organization. The contract, valued at $1,663,800.00, is for the delivery of blood and blood-related products to support healthcare programs for veterans, military personnel, and Native American communities. Vitalant is an experienced provider of blood services, with expertise in blood collection, processing, testing, research, and...
- This is a federal contract award from the Veterans Integrated Service Network 9 (VISN 9), a division of the Department of Veterans Affairs, to Vitalant, a non-profit organization that specializes in blood collection, processing, testing, and research. The contract is for the provision of various blood products as required throughout the year, with a period of performance from October 17, 2023, to September 30, 2024. The contract type is a Purchase Order with a Firm Fixed Price pricing...
- This is a Firm Fixed Price delivery order contract awarded by the Department of Veterans Affairs (VA) to Vitalant, a non-profit organization headquartered in Scottsdale, Arizona. The contract, valued at $738,745.83, is for the provision of blood products and services to VA medical facilities in Phoenix, Prescott, and Albuquerque. The contract has an ultimate completion date of October 18, 2026. Vitalant, the prime contractor, is the nation's largest independent blood services provider, serving...
- The Department of Veterans Affairs' Veterans Integrated Service Network 21 awarded a $228,712.17 firm fixed-price delivery order to Vitalant (through its division Vitalant Research Institute) for blood and blood products, with an ultimate completion date of September 30, 2026. This delivery order, awarded on December 1, 2025, carries no set-aside designation, allowing Vitalant to compete in the open federal procurement process. The work will be performed in Scottsdale, Arizona, where Vitalant...
- 36C26326D0009Indefinite Delivery Contract
- 36C26326D0009-36C26326N0208Delivery Order
This is a federal contract award for "BLOOD PRODUCTS AND TRANSFUSION SERVICES" valued at $199,902.62. The contract was awarded to Vitalant, a non-profit organization headquartered in Scottsdale, Arizona, which specializes in blood collection, processing, testing, research, and medical services for federal agencies. The contract was awarded by the Veterans Integrated Service Network 23, a civilian agency, and has an ultimate completion date of September 30, 2026. The contract is a firm fixed-price delivery order, and there was no set-aside designation used. Vitalant has extensive experience providing blood products and related services to federal agencies, including the Department of Veterans Affairs, Indian Health Service, and Defense Health Agency. The organization has been awarded numerous federal contracts and grants, primarily focused on supplying blood components, plasma, and specialized testing services, as well as conducting advanced medical research in areas such as HIV, cardiovascular disease, and transfusion medicine.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $199.9k | 10/1/25 |